EP 1523549 A2 20050420 - OLIGODENDROCYTES DERIVED FROM HUMAN EMBRYONIC STEM CELLS FOR REMYELINATION AND TREATMENT OF SPINAL CORD INJURY
Title (en)
OLIGODENDROCYTES DERIVED FROM HUMAN EMBRYONIC STEM CELLS FOR REMYELINATION AND TREATMENT OF SPINAL CORD INJURY
Title (de)
OLIGODENDROCYTEN AUS HUMANER EMBRYONALER STAMMZELLEN FÜR REMYELINISIERUNG UND BEHANDLUNG VON RÜCKENMARKVERLETZUNGEN
Title (fr)
OLIGODENDROCYTES DERIVES DE CELLULES SOUCHES EMBRYONNAIRES HUMAINES POUR REMYELINISATION ET TRAITEMENT DE LESION DE LA MOELLE EPINIERE
Publication
Application
Priority
- IB 0303539 W 20030711
- US 39538202 P 20020711
- US 40681703 A 20030404
Abstract (en)
[origin: US2004009593A1] This invention provides populations of neural cells bearing markers of glial cells, such as oligodendrocytes and their precursors. The populations are generated by differentiating pluripotent stem cells such as human embryonic stem cells under conditions that promote enrichment of cells with the desired phenotype or functional capability. Various combinations of differentiation factors and mitogens can be used to produce cell populations that are over 95% homogeneous in morphological appearance, and the expression of oligodendrocyte markers such as GalC. The cells are capable of forming myelin sheaths, and can be used therapeutically improve function of the central nervous system.
IPC 1-7
IPC 8 full level
C12Q 1/02 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); C12N 5/079 (2010.01); C12N 5/0797 (2010.01); A61K 35/12 (2015.01)
CPC (source: EP GB US)
A61K 35/12 (2013.01 - GB); A61P 25/00 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 27/02 (2018.01 - EP); C12N 5/0622 (2013.01 - EP GB US); C12N 5/0623 (2013.01 - EP GB US); G01N 33/50 (2013.01 - GB); A61K 35/12 (2013.01 - EP US); C12N 2501/115 (2013.01 - EP US); C12N 2501/395 (2013.01 - EP US); C12N 2503/02 (2013.01 - EP US); C12N 2506/02 (2013.01 - EP US)
Citation (examination)
- WO 0168815 A1 20010920 - UNIV MONASH [AU], et al
- MUJTABA T ET AL: "Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells", DEVELOPMENTAL BIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 214, no. 1, 1 October 1999 (1999-10-01), pages 113 - 127, XP002216609, ISSN: 0012-1606, DOI: 10.1006/DBIO.1999.9418
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2004009593 A1 20040115; US 7285415 B2 20071023; AU 2003250477 A1 20040202; AU 2003250477 B2 20080703; CA 2489203 A1 20040122; CA 2489203 C 20140311; CN 103396993 A 20131120; CN 103396993 B 20181207; CN 1852971 A 20061025; CN 1852971 B 20130612; EP 1523549 A2 20050420; EP 2273268 A2 20110112; EP 2273268 A3 20130619; GB 0502774 D0 20050316; GB 2407822 A 20050511; GB 2407822 B 20060222; HK 1093219 A1 20070223; JP 2005532079 A 20051027; JP 2011155978 A 20110818; JP 4823689 B2 20111124; JP 5514756 B2 20140604; WO 2004007696 A2 20040122; WO 2004007696 A3 20040422
DOCDB simple family (application)
US 40681703 A 20030404; AU 2003250477 A 20030711; CA 2489203 A 20030711; CN 03816184 A 20030711; CN 201310161694 A 20030711; EP 03764084 A 20030711; EP 10175854 A 20030711; GB 0502774 A 20030711; HK 06113936 A 20061219; IB 0303539 W 20030711; JP 2005505090 A 20030711; JP 2011047716 A 20110304